Sustainable Pharmaceutical Packaging Market (2026 - 2033)

Sustainable Pharmaceutical Packaging Market Summary

The global sustainable pharmaceutical packaging market size was valued at USD 112.9 billion in 2025 and is projected to grow from USD 128.7 billion in 2026 to USD 285.6 billion by 2033, at a CAGR of 12.1% from 2026 to 2033. The North America market held the largest share of 33.8% of the global market in 2025. The industry is driven by several key factors, reflecting a growing awareness of environmental issues and regulatory pressures.

One of the primary drivers is the increasing focus on reducing plastic waste and carbon footprint across industries, including pharmaceuticals. This has led to a surge in demand for eco-friendly packaging materials such as biodegradable plastics, recycled paper, and plant-based alternatives.

In addition, regulatory changes and government initiatives are playing a crucial role in shaping the sustainable pharmaceutical packaging landscape. Many countries have implemented stricter regulations on single-use plastics and are encouraging the use of recyclable materials. For instance, the European Union's Circular Economy Action Plan aims to make all packaging reusable or recyclable by 2030, pushing pharmaceutical companies to innovate in their packaging designs. This has led to the development of solutions like blister packs made from mono-materials that are easier to recycle.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Consumer awareness and preferences are another significant driving factor for the sustainable pharmaceutical packaging industry. As patients become more environmentally conscious, there's a growing demand for pharmaceuticals packaged in sustainable materials. This trend is pushing companies to not only adopt greener packaging but also to communicate their sustainability efforts to consumers.

Major companies in the industry are undertaking multiple strategic initiatives to enhance their competitive position and capitalize on market opportunities. These strategies include launching new products, engaging in mergers and acquisitions, forming partnerships & collaborations, and expanding into new geographic regions. For instance, in February 2024, Sanofi Consumer Healthcare joined the Blister Pack Collective, formed by PA Consulting and PulPac, to develop recyclable fibre-based blister packs aimed at reducing plastic waste in pharmaceutical packaging. The initiative seeks to replace problematic plastics like PVC, which contribute to the 100,000 tonnes of plastic used annually in medical packaging, with PulPac's Dry Molded Fiber technology, which boasts an 80% lower CO₂ footprint compared to traditional materials. Hence, this strategic decision was intended to enhance the sustainability of its packaging product and inspire industry-wide changes towards environmentally friendly packaging solutions.

Market Dynamics

Market Concentration & Characteristics

Major sustainable pharmaceutical packaging companies operating in the industry include Amcor plc, Berry Global Inc., Sonoco Products Company, WestRock Company, CCL Healthcare, SGD Pharma, OLIVER, Gerresheimer AG, West Pharmaceutical Services, Inc.; Nottingham Spirk, Crown Packaging Corp., Nipro Europe Group Companies, Origin Pharma Packaging, Syntegon Technology GmbH, and Bormioli Pharma S.p.A.

Companies are increasingly focusing on the introduction of sustainable packaging practices in the industry. For instance, in June 2024, Keystone Folding Box Co launched a new line of paper-based blister packs for the pharmaceutical industry, offering an eco-friendly alternative to traditional plastic blister packs. The paper-based packs are made from renewable materials and are designed to provide the same level of protection and functionality as plastic packs, while reducing the environmental impact of packaging waste.

To learn more about this report, Download Free Sample Report

In June 2022, Constantia Flexibles introduced a new recycle-ready laminate called PERPETUA ALTA, which is made from polypropylene and features improved chemical resistance. This laminate is designed for use in pharmaceutical products and is claimed to be a mono-material, making it easier to recycle. PERPETUA ALTA can withstand various chemical conditions, including hydro-alcoholic gel under accelerated aging conditions, which is similar to the performance of aluminum-containing multi-material packaging.

Material Insights

Based on material, the industry has been segmented into plastics, paper & paperboard, glass, metal, and others. Plastic dominated the overall market with a share of over 36.6% in 2025. This positive outlook can be attributed to its versatility, cost-effectiveness, and ability to meet stringent regulatory requirements while offering eco-friendly alternatives. Additionally, the lightweight nature of plastic packaging also contributes to its popularity in sustainable pharmaceutical packaging.

The paper & paperboard segment is growing due to its recyclability and biodegradability. Paper-based pharmaceutical packaging includes folding cartons, labels, and inserts. Also, these materials can be easily printed with essential information, providing a practical solution for labeling and branding while maintaining compliance with strict regulatory standards. Companies such as GSK plc and Pfizer Inc adopted paper-based packaging solutions to meet their sustainability goals, showcasing the material's reliability and effectiveness.

Process Insights

Based on the process, the market is segmented into recyclable, reusable, and biodegradable. The recyclable process segment dominated the industry and accounted for the largest revenue share of over 63.1% in 2025 and is projected to progress at the fastest CAGR of 11.8% over the forecast period. This category includes glass bottles, aluminum containers, and certain types of plastic that can be collected, cleaned, and repurposed into new packaging or other products. Recyclable packaging helps reduce waste and conserve resources by keeping materials in circulation longer, though the effectiveness depends on proper disposal and recycling infrastructure.

Reusable pharmaceutical packaging is designed for multiple uses without significant degradation. This category may include durable containers, refillable dispensers, or packaging systems that can be sanitized and repurposed. Reusable options often have a higher upfront cost but can lead to long-term savings and reduced environmental impact by minimizing the need for single-use packaging.

Biodegradable pharmaceutical packaging is made from materials that can naturally decompose into non-toxic components when exposed to environmental conditions. These may include packaging derived from plant-based materials, such as corn starch or sugarcane, or specially designed polymers that break down more quickly than traditional plastics.

Product Insights

Based on the product, the industry is segmented into primary, secondary, and tertiary packaging. The primary segment dominated the market and accounted for the largest revenue share of over 76.4% in 2025. This outlook is due to its critical role in ensuring the safety, efficacy, and integrity of pharmaceutical products. Primary packaging in sustainable pharmaceutical packaging refers to the materials that come into direct contact with the medication or drug product. This includes items such as blister packs, bottles, vials, ampoules, and sachets made from eco-friendly materials.

To learn more about this report, Download Free Sample Report

The secondary packaging product segment encompasses the packaging products used to group and protect primary packages. This typically includes prescription containers and pharmaceutical packaging accessories. In sustainable pharmaceutical packaging, secondary packaging often utilizes recycled paperboard, minimizes the use of inks and adhesives, and incorporates designs that reduce material waste.

Tertiary packaging, also known as transit packaging, is used for bulk handling, warehouse storage, and shipping of pharmaceutical products. This includes corrugated boxes, pallets, and shrink wrap. Sustainable approaches in tertiary packaging focus on using recycled and recyclable materials, optimizing package design to reduce empty space and improve shipping efficiency, and exploring reusable options such as plastic pallets or returnable transit packaging systems.

Regional Insights

North America dominated the market and accounted for the largest revenue share of over 33.8% in 2025. Stringent regulations and environmental policies in the region are driving pharmaceutical companies to adopt more sustainable packaging solutions. The United States Environmental Protection Agency (EPA) and Health Canada have implemented strict guidelines for reducing packaging waste and promoting recyclable materials. This regulatory pressure has led many pharmaceutical firms to invest in eco-friendly packaging alternatives, such as biodegradable plastics, recycled materials, and reduced packaging designs. For instance, Johnson & Johnson Services, Inc. aims to make 100% of its packaging reusable, recyclable, or compostable by 2025. These major companies are setting trends and pushing the entire market towards more sustainable practices.

To learn more about this report, Download Free Sample Report

U.S. Sustainable Pharmaceutical Packaging Market Trends

The sustainable pharmaceutical packaging market in the U.S. is primarily driven by the growing consumer awareness and demand for sustainable products in the U.S. healthcare sector. Patients and healthcare providers are increasingly considering environmental factors when making purchasing decisions. This has prompted pharmaceutical companies to prioritize sustainable packaging as a competitive advantage. For instance, in June 2023, Cabinet Health, P.B.C., a New York-based sustainable healthcare company, launched a nationwide pill bottle recycling program aimed at tackling the environmental impact of pharmaceutical plastics. With an estimated 165 billion plastic pill bottles entering landfills and oceans annually, this program seeks to raise awareness about plastic waste and promote sustainable pharmaceutical packaging solutions.                      

Asia Pacific Sustainable Pharmaceutical Packaging Market Trends

The sustainable pharmaceutical packaging market in Asia Pacific is projected to expand at the fastest CAGR of 15.2% from 2026 to 2033. Rapid industrialization and economic growth in countries such as China, India, and Southeast Asian nations have led to increased pharmaceutical production and consumption. This growth has created a need for sustainable packaging solutions to mitigate environmental impacts. Governments in these countries are implementing stricter regulations on plastic usage and waste management, pushing pharmaceutical companies to adopt eco-friendly packaging alternatives, thus driving the market growth in the region.

The sustainable pharmaceutical packaging market in Southeast Asia is rapidly growing due to theexpanding pharmaceutical industry, coupled with increasing environmental awareness and supportive government policies. One of the primary drivers is the region's aging population, which has led to increased demand for pharmaceuticals. Singapore, Malaysia, and Thailand have invested heavily in their healthcare infrastructure, thus creating a need for more sustainable packaging solutions.

Europe Sustainable Pharmaceutical Packaging Market Trends

The sustainable pharmaceutical packaging market in Europe held a revenue share of over 25.1% in 2025. Europe has implemented stringent regulations and policies promoting sustainability across industries, including pharmaceuticals. The European Union's Circular Economy Action Plan and the European Green Deal have set ambitious targets for reducing waste and improving recyclability. This regulatory environment has pushed pharmaceutical companies to invest in sustainable packaging solutions. For example, companies such as Novartis AG and Merck KGaA have committed to making 100% of their packaging recyclable or reusable by 2025 and 2030, respectively.

The UK sustainable pharmaceutical packaging market is driven by stringent regulations and policies promoting sustainability across industries, including pharmaceuticals. The government's commitment to reducing plastic waste and carbon emissions has pushed pharmaceutical companies to adopt eco-friendly packaging solutions. For example, the UK Plastics Pact, a collaborative initiative between businesses, NGOs, and the government, has set ambitious targets for reducing plastic waste, which has directly impacted pharmaceutical packaging practices in the country.

Central & South America Sustainable Pharmaceutical Packaging Market Trends

The sustainable pharmaceutical packaging market in Central & South America is projected to expand at a moderate CAGR from 2026 to 2033, owing to a growing awareness of environmental issues, coupled with stricter regulations on plastic use and waste management in the region. Countries such as Brazil, Argentina, and Colombia have implemented policies to reduce single-use plastics and promote sustainable packaging solutions. This regulatory push has incentivized pharmaceutical companies to adopt eco-friendly packaging options. For instance, Brazil's National Solid Waste Policy has encouraged the use of recyclable and biodegradable materials in pharmaceutical packaging.

Middle East & Africa Sustainable Pharmaceutical Packaging Market Trends

The sustainable pharmaceutical packaging market in the Middle East & Africa is influenced by growing environmental awareness and stricter regulations in the region. A significant increase in healthcare investments across the Middle East, particularly in countries such as Saudi Arabia, UAE, and Qatar are expected to positively influence the sustainable pharmaceutical packaging market in the region.

According to the National Industrial Development Center (NIDC), in August 2023, Saudi Arabia's pharmaceutical sector is set for substantial growth following the signing of a trilateral memorandum of understanding by the Kingdom's National Industrial Development Center, Jubail Pharma, and RR Holding Co. This agreement aims to enhance the local production of chemical compounds essential for manufacturing pharmaceutical products. Hence, the partnership is expected to trigger the demand for the pharmaceutical packaging products, thus positively influencing the market in the country.

Key Sustainable Pharmaceutical Packaging Companies Insights

The competitive landscape of the sustainable pharmaceutical packaging market is evolving quickly, driven less by price competition and more by innovation, regulatory compliance, and sustainability performance. It is not a fully consolidated market, while a few global players hold strong positions, there is still significant room for smaller and specialized companies to compete. This creates a dynamic environment where leadership is established, but not unchallenged.

The market is fragmented, with the presence of both large multinational companies and numerous smaller regional and local players. The market has been witnessing a significant number of new product launches, merger & acquisitions, and expansions over the past few years.

Recent Developments

• In February 2024, Schreiner Group, a Germany-based company specializing in pharmaceutical labeling and packaging solutions, launched a new sustainable closure seal called Needle-Trap Closure Seal. This product is designed to prevent needles from being reused and to ensure the integrity of pharmaceutical packaging. The closure seal is made from recyclable materials and is intended to contribute to the company's sustainability efforts while maintaining the safety and security of its products.

• In August 2023, Amcor plc announced the acquisition of a scalable flexible packaging plant in the high-growth Indian market. This strategic move involves the acquisition of Phoenix Flexibles, expanding the company’s capacity in India. The company already operates four flexible packaging plants in India. This acquisition aligns with the company’s position as a global leader in developing sustainable packaging solutions.

Global Sustainable Pharmaceutical Packaging Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global sustainable pharmaceutical packaging market report on the basis of material, product, process, and region:

To learn more about this report, Download Free Sample Report

• Material Outlook (Revenue, USD Million, 2021 - 2033)

  • Plastics

  • Paper & Paperboard

  • Glass

  • Metal

  • Others

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Primary

    • Plastic Bottles

    • Caps & Closures

    • Parenteral Containers

    • Blister Packs

    • Prefillable Inhalers

    • Pouches

    • Medication Tubes

    • Others

  • Secondary

    • Prescription Containers

    • Pharmaceutical Packaging Accessories

  • Tertiary

• Process Outlook (Revenue, USD Million, 2021 - 2033)

  • Recyclable

  • Reusable

  • Biodegradable

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

  • Asia Pacific

    • China

    • India

    • Japan

    • South Korea

    • Australia

  • Central & South America

    • Brazil

    • Argentina

  • Middle East & Africa

    • Saudi Arabia

    • UAE

    • South Africa

Delivered Customizations

This report has been delivered with the following In-depth customizations